Heineken warns British pubs that weight-loss drugs could cut beer drinking

Heineken, the world's second-largest brewer, warned British pubs and bars in an early October presentation that weight-loss drugs such as Ozempic and Wegovy could reduce the desire to drink. It warned of "fullness and fewer serves" of pints. Carlsberg told Reuters that data does not support the view that these drugs affect beer consumption.